Colchicine for insulin sensitivity in type 1 diabetes
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests whether a daily oral medication called colchicine can improve how your body responds to insulin. It is for people with type 1 diabetes who have ongoing low-level inflammation and are already using a continuous glucose monitor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You've had type 1 diabetes for over 5 years.
- Your C-peptide is less than 200 pmol/L, meaning your body makes little to no insulin.
- You are between 18 and 80 years old.
- You use a continuous glucose monitor (CGM) and your long-term blood sugar (HbA1c) is between 42 and 75 mmol/mol.
- Your insulin routine has been stable for at least 3 months, and you are willing to avoid certain anti-inflammatory drugs and other medications during the study.
- You have a blood test showing low-level inflammation (hs-CRP of 2 mg/L or higher) and no major liver, kidney, or blood disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if colchicine, an anti-inflammatory medicine, can help people with a type of heart failure where the heart pumps well but is stiff and inflamed. You may join if your heart failure recently worsened and you have signs of inflammation in your blood.
This trial is testing whether colchicine, a medication used for gout, can help people with a specific type of heart failure where the heart pumps normally but is stiff. If you have heart failure with preserved pumping and certain signs of inflammation, this study might be a good fit.
This trial tests if a low dose of colchicine can help people who cannot take statins due to side effects. It aims to see if colchicine is safe and effective for lowering inflammation and improving cholesterol management.
This Phase 3 study tests whether colchicine and a special type of aspirin can lower the risk of future heart attacks, strokes, or other major heart problems in people with type 2 diabetes who have not had a prior heart event. It aims to reduce cardiovascular risk using medicines that may calm inflammation and protect blood vessels.
This trial tests if a low dose of colchicine, a medicine that reduces inflammation, can help improve blood vessel and bone health in people with moderate chronic kidney disease.
This trial tests whether adding a targeted anti-inflammatory drug to standard care can prevent future heart attacks or strokes in people with high-risk chronic coronary artery disease. It is for people who have a moderate narrowing in a heart artery with a vulnerable plaque and signs of inflammation.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.